RTX Corporation RTX posts Q4 2025 earnings beat and 97 percent year over year revenue growth shares dip slightly Lucid Group Inc LCID Secures 500M Uber Investment Expands Robotaxi Fleet Commitment to 35000 Units DuPont de Nemours Inc DD Corian Design Launches 2026 NatureInspired Surface Collection to Expand Commercial Segment Footprint Merck Co MRK Receives FDA Priority Review for KEYTRUDA Combination Regimens in MuscleInvasive Bladder Cancer Vertex Pharmaceuticals Incorporated VRTX NearTerm Price Underperformance Amid Broad Market Rally LongTerm Fundamental Outlook Remains Constructive CODIB CompassBPref reaffirms stable quarterly distribution commitments for its 7875 fixedtofloating preferred share series Cartesian Therapeutics RNAC Stock Underweight Underperforming 20260420 Pebblebrook PEB LongTerm View Pebblebrook posts 23 EPS beat on narrower Q4 loss YYGH YY Group CEO highlights planned overseas market expansion as core strategic priority for the coming fiscal year Regeneron Pharmaceuticals REGN SoFi Technologies SOFI Stock Strong Sell Rating Underperforming 20260420